COVID-19 Medtech Lessons: Data Point To ‘Healthy Industry In An Unhealthy Time’ But Business Models Must Change

Ernst &Young’s annual Pulse of the Industry report says strong R&D spending by medtechs in 2019 bodes well for their post-pandemic recovery as industry leaders point to long-term changes to the industry that companies must navigate when future-proofing their business models.